Abstract
Prostatic adenocarcinoma is one of the most commonly occurring cancers among men in the world, and it also the most curable cancer when it is detected early. Multiparametric MRI (mpMRI) combines anatomic and functional prostate imaging techniques, which have been shown to produce high sensitivity and specificity in cancer localization, which is important in planning biopsies and focal therapies. However, in previous investigations, lesion localization was achieved mainly by manual segmentation, which is time-consuming and prone to observer variability. Here, we developed an algorithm based on locality alignment discriminant analysis (LADA) technique, which can be considered as a version of linear discriminant analysis (LDA) localized to patches in the feature space. Sensitivity, specificity and accuracy generated by the proposed algorithm in five prostates by LADA were 52.2%, 89.1% and 85.1% respectively, compared to 31.3%, 85.3% and 80.9% generated by LDA. The delineation accuracy attainable by this tool has a potential in increasing the cancer detection rate in biopsies and in minimizing collateral damage of surrounding tissues in focal therapies.
Original language | English (US) |
---|---|
Title of host publication | Medical Imaging 2017 |
Subtitle of host publication | Computer-Aided Diagnosis |
Editors | Samuel G. Armato, Nicholas A. Petrick |
Publisher | SPIE |
ISBN (Electronic) | 9781510607132 |
DOIs | |
State | Published - 2017 |
Externally published | Yes |
Event | Medical Imaging 2017: Computer-Aided Diagnosis - Orlando, United States Duration: Feb 13 2017 → Feb 16 2017 |
Publication series
Name | Progress in Biomedical Optics and Imaging - Proceedings of SPIE |
---|---|
Volume | 10134 |
ISSN (Print) | 1605-7422 |
Conference
Conference | Medical Imaging 2017: Computer-Aided Diagnosis |
---|---|
Country/Territory | United States |
City | Orlando |
Period | 2/13/17 → 2/16/17 |
Bibliographical note
Publisher Copyright:© 2017 SPIE.
Keywords
- Lesion localization
- Locality alignment discriminant analysis (LADA)
- Multiparametric MRI (mpMRI)
- Prostate cancer